Methods for controlling progression of hyperparathyroidism with calcifediol and compositions for use therein

JP2025031720A5Pending Publication Date: 2025-06-24AIRGEN PHARMA LTD
0 Cites 0 Cited by

Patent Information

Application Number
JP2024204631
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-02-06
Filing Date
2024-11-25
Publication Date
2025-06-24

Smart Images

  • Figure 00000044_0000
    Figure 00000044_0000
  • Figure 00000044_0001
    Figure 00000044_0001
  • Figure 00000045_0000
    Figure 00000045_0000
Patent Text Reader

Abstract

To provide methods and compositions for regulating hyperparathyroidism.SOLUTION: One aspect of the disclosure is a method for preventing, halting or reversing the SHPT progression in a subject, e.g., a human adult, defined as an increase in iPTH by >10% from the pretreatment baseline, the method comprising effective administration of 25-hydroxyvitamin D to increase and maintain serum total 25-hydroxyvitamin D in the patient to a concentration greater than 50 ng / mL, optionally at least 50.8 ng / mL, optionally at least 51 ng / mL or at least 60 ng / mL, and thereby preventing, halting, or reversing SHPT progression in the patient.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art